BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 23450347)

  • 21. CXCR3 promotes the production of IgG1 autoantibodies but is not essential for the development of lupus nephritis in NZB/NZW mice.
    Moser K; Kalies K; Szyska M; Humrich JY; Amann K; Manz RA
    Arthritis Rheum; 2012 Apr; 64(4):1237-46. PubMed ID: 22006377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon-gamma is required for lupus nephritis in mice treated with the hydrocarbon oil pristane.
    Richards HB; Satoh M; Jennette JC; Croker BP; Yoshida H; Reeves WH
    Kidney Int; 2001 Dec; 60(6):2173-80. PubMed ID: 11737591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE.
    Urbonaviciute V; Fürnrohr BG; Meister S; Munoz L; Heyder P; De Marchis F; Bianchi ME; Kirschning C; Wagner H; Manfredi AA; Kalden JR; Schett G; Rovere-Querini P; Herrmann M; Voll RE
    J Exp Med; 2008 Dec; 205(13):3007-18. PubMed ID: 19064698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted IgA Fc receptor I (FcαRI) therapy in the early intervention and treatment of pristane-induced lupus nephritis in mice.
    Liu C; Kanamaru Y; Watanabe T; Tada N; Horikoshi S; Suzuki Y; Liu Z; Tomino Y
    Clin Exp Immunol; 2015 Sep; 181(3):407-16. PubMed ID: 25907714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pristane-induced autoimmunity in germ-free mice.
    Mizutani A; Shaheen VM; Yoshida H; Akaogi J; Kuroda Y; Nacionales DC; Yamasaki Y; Hirakata M; Ono N; Reeves WH; Satoh M
    Clin Immunol; 2005 Feb; 114(2):110-8. PubMed ID: 15639644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Annexin A1 as a target for managing murine pristane-induced systemic lupus erythematosus.
    Mihaylova N; Bradyanova S; Chipinski P; Herbáth M; Chausheva S; Kyurkchiev D; Prechl J; Tchorbanov AI
    Autoimmunity; 2017 Jun; 50(4):257-268. PubMed ID: 28300427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
    Lichtnekert J; Rupanagudi KV; Kulkarni OP; Darisipudi MN; Allam R; Anders HJ
    J Immunol; 2011 Sep; 187(6):3413-21. PubMed ID: 21849682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High frequency of autoantibody-secreting cells and long-lived plasma cells within inflamed kidneys of NZB/W F1 lupus mice.
    Starke C; Frey S; Wellmann U; Urbonaviciute V; Herrmann M; Amann K; Schett G; Winkler T; Voll RE
    Eur J Immunol; 2011 Jul; 41(7):2107-12. PubMed ID: 21484784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells.
    Patole PS; Gröne HJ; Segerer S; Ciubar R; Belemezova E; Henger A; Kretzler M; Schlöndorff D; Anders HJ
    J Am Soc Nephrol; 2005 May; 16(5):1326-38. PubMed ID: 15772251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonbilayer Phospholipid Arrangements Are Toll-Like Receptor-2/6 and TLR-4 Agonists and Trigger Inflammation in a Mouse Model Resembling Human Lupus.
    Wong-Baeza C; Tescucano A; Astudillo H; Reséndiz A; Landa C; España L; Serafín-López J; Estrada-García I; Estrada-Parra S; Flores-Romo L; Wong C; Baeza I
    J Immunol Res; 2015; 2015():369462. PubMed ID: 26568960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of systemic lupus erythematosus-like syndrome in syngeneic mice by immunization with activated lymphocyte-derived DNA.
    Qiao B; Wu J; Chu YW; Wang Y; Wang DP; Wu HS; Xiong SD
    Rheumatology (Oxford); 2005 Sep; 44(9):1108-14. PubMed ID: 15840592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of administration of apoptotic blebs on disease development in lupus mice.
    Fransen JH; Berden JH; Koeter CM; Adema GJ; Van Der Vlag J; Hilbrands LB
    Autoimmunity; 2012 Jun; 45(4):290-7. PubMed ID: 22390780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
    Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
    J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of haemorrhagic pulmonary capillaritis: another manifestation of Pristane-induced lupus.
    Chowdhary VR; Grande JP; Luthra HS; David CS
    Rheumatology (Oxford); 2007 Sep; 46(9):1405-10. PubMed ID: 17576695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process.
    Papadimitraki ED; Choulaki C; Koutala E; Bertsias G; Tsatsanis C; Gergianaki I; Raptopoulou A; Kritikos HD; Mamalaki C; Sidiropoulos P; Boumpas DT
    Arthritis Rheum; 2006 Nov; 54(11):3601-11. PubMed ID: 17075805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apoptosis-induced acetylation of histones is pathogenic in systemic lupus erythematosus.
    Dieker JW; Fransen JH; van Bavel CC; Briand JP; Jacobs CW; Muller S; Berden JH; van der Vlag J
    Arthritis Rheum; 2007 Jun; 56(6):1921-33. PubMed ID: 17530637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostaglandin E2-mediated dysregulation of proinflammatory cytokine production in pristane-induced lupus mice.
    Chae BS; Shin TY; Kim DK; Eun JS; Leem JY; Yang JH
    Arch Pharm Res; 2008 Apr; 31(4):503-10. PubMed ID: 18449509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of microbial stimulation on hypergammaglobulinemia and autoantibody production in pristane-induced lupus.
    Hamilton KJ; Satoh M; Swartz J; Richards HB; Reeves WH
    Clin Immunol Immunopathol; 1998 Mar; 86(3):271-9. PubMed ID: 9557160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B cell autophagy mediates TLR7-dependent autoimmunity and inflammation.
    Weindel CG; Richey LJ; Bolland S; Mehta AJ; Kearney JF; Huber BT
    Autophagy; 2015; 11(7):1010-24. PubMed ID: 26120731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein array autoantibody profiles for insights into systemic lupus erythematosus and incomplete lupus syndromes.
    Li QZ; Zhou J; Wandstrat AE; Carr-Johnson F; Branch V; Karp DR; Mohan C; Wakeland EK; Olsen NJ
    Clin Exp Immunol; 2007 Jan; 147(1):60-70. PubMed ID: 17177964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.